Significant acceptances by SCHWARZ shareholders for UCB tender offer
13-Dec-2006
Roch Doliveux, CEO of UCB, said, "I am delighted with the results of the tender offer so far. The current level of acceptances already received from SCHWARZ shareholders will allow the two companies to capture significant benefits of this exciting business combination, on which our resources will be focused. I thank shareholders for their support in building UCB as the next generation biopharmaceutical leader."
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.